Is a complete TPEX/6696 research report available?

Question

Accepted Answer

No complete published report is available for tpex/6696 (TPEX/6696) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	97.3B
Net income (ttm)	-1.6B
EPS (ttm)	-NT$1.94
Shares out	595M
Volume	14,838,463
Beta	-0.10

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 96.9B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	30.64
Isin	TW0006696008
Last refreshed	2026-09-12
Market cap	TWD 97.3B
Price	TWD 163
Price currency	TWD
Sector	Healthcare
Sector PE	83.64
Sector PE Fwd	26.88
Sic	2836
Symbol	tpex/6696
Website	https://www.linbioscience.com

Metric	Value
Earnings Yield	-1.65%
FCF yield	-2.35%
P/B ratio	3.81x

Metric	Value
Net Income	TWD -1.6B
Net Income Growth Years	0%
ROA	-15.73
Roa5y	-19.29
ROCE	-15.49
ROE	-21.83
Roe5y	-39.84
ROIC	-16

Metric	Value
Cagr1y	939.88%
Cagr3y	136.81%
Cagr5y	64.01%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

TPEX/6696 (TPEX/6696)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6696

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6696 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6696

Frequently asked questions

Metric	Value
Assets	TWD 26.1B
Cash	TWD 16.6B
Current Assets	TWD 16.9B
Current Liabilities	TWD 442.7M
Debt	TWD 92.7M
Debt Equity	TWD 0
Debt FCF	TWD -0.04
Equity	TWD 25.6B
Interest Coverage	-2,058.3
Liabilities	TWD 507.4M
Long Term Assets	TWD 9.2B
Long Term Liabilities	TWD 64.7M
Net Cash	TWD 16.5B
Net Cash By Market Cap	TWD 16.97
Net Cash Growth	217.75%
Net Debt Equity	TWD -0.65
Tangible Book Value	TWD 10.5B
Tangible Book Value Per Share	TWD 12.64
WACC	3.69

Metric	Value
Current ratio	38.08
Net Working Capital	TWD -154.7M
Quick ratio	37.54
Working Capital	TWD 16.4B

Metric	Value
1Y total return	938.22%
200-day SMA	49.1
3Y total return	1,228.71%
50-day SMA	80.25
50-day SMA vs 200-day SMA	50over200
5Y total return	1,086.42%
All Time High	200
All Time High Change	-18.5%
All Time High Date	2026-09-07
All Time Low	2.7
All Time Low Change	5,937.04%
All Time Low Date	2019-11-18
ATR	17.13
Beta	-0.1
Beta1y	-0.25
Beta2y	0.18
Ch YTD	310.6
High	169
High52	200
High52 Date	2026-09-07
High52ch	-18.75%
Low	150
Low52	15.25
Low52 Date	2025-09-11
Low52ch	965.57%
Ma50ch	103.11%
Price vs 200-day SMA	231.99%
RSI	74.82
RSI Monthly	92.58
RSI Weekly	93.34
Sharpe ratio	3.08x
Sharpe Ratio3y	1.56x
Sharpe Ratio5y	0.89x
Sortino ratio	7.44
Sortino Ratio3y	3.25
Sortino Ratio5y	1.76
Total Return	-3.46%
Tr YTD	310.6
Tr1m	126.39%
Tr1w	12.03%
Tr3m	316.35%

Metric	Value
Float	649,554,720%
Net Borrowing	-21,545,000
Shares Insiders	25.85%
Shares Institutions	9.62%
Shares Out	595,000,000
Shares Qo Q	0.18%
Shares Yo Y	3.46%

Metric	Value
Adjusted FCF	TWD -3.7B
Adjusted OCF	-3,665,653,000
Average Volume	21,432,160.75x
Bv Per Share	12.78
CAPEX	TWD -26.1M
Ch1m	126.4
Ch1w	12.03
Ch1y	938.2
Ch3m	316.3
Ch3y	1,219.8
Ch5y	1,051.9
Ch6m	311.6
Change	-3.56%
Change From Open	-2.99
Close	168.5
Days Gap	-0.59
Depreciation Amortization	8,851,000
Dollar Volume	2,411,250,237.5
Earnings Date	2026-11-13
EBIT	TWD -4B
EBITDA	TWD -4B
EPS	TWD -1.94
F Score	0
FCF	TWD -2.3B
FCF EV Yield	-2.36x
FCF Per Share	TWD -3.85
Financing CF	20,603,225,000
Fiscal Year End	December
Income Tax	TWD -53.6M
Investing CF	-11,306,656,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2026-06-30
Last Split Date	2026-08-31
Last Split Type	Forward
Ma150	53.11
Ma150ch	206.89%
Ma20	111.5
Ma20ch	46.2%
Net CF	8,043,084,000
Next Earnings Date	2026-11-13
Open	167.5
Position In Range	65.79
Ppne	111,136,000
Price Date	2026-09-11
Ptbv Ratio	9.28
Relative Volume	0.69x
Share Based Comp	1,400,930,000
Tr6m	311.62%
Volume	14,838,463